Skip to main content
. 2020 Dec 17;6(4):373. doi: 10.3390/jof6040373

Table 2.

Summary of studies undertaken which support the investigation of PC945 in clinical studies.

Binding assays in vitro to assess potential for off-target interactions
In vitro and in vivo genotoxicology
Safety pharmacology (cardiovascular and behavioural)
Oral bioavailability and interaction with CYP enzymes
14 day- and 13 week-repeat dose safety assessment (inhaled dosing) in rats and dogs
Reproductive toxicology
Phototoxicology